Jerome Ritz
Executive Director, Connell and O'Reilly Families Cell Manipulation Core Facility · Mass General Brigham
Credentials: · ·
History
- Present
Connell and O'Reilly Families Cell Manipulation Core Facility · Mass General Brigham
- Present
- 1978–1979
- 1972–1975
University of Wisconsin Hospitals
1968–1972
Research
An immunogenic personal neoantigen vaccine for patients with melanoma
Nature · 2017 · 2,312 citations
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Nature · 2019 · 1,159 citations
Interleukin-2 and regulatory T cells in graft-versus-host disease
New England Journal of Medicine · 2011 · 929 citations
223 papers · 3 as a fellow
133 papers
121 papers
119 papers
110 papers
103 papers · 1 as a fellow
69 papers · 5 as a fellow
- SS
67 papers
Grants
- 2026–2031
- 1997–2030
Development of Novel Therapeutic Strategies in Human Leukemias
National Cancer Institute · P01
Project lead · $2.9M · Dana-Farber Cancer Inst
- 2022–2027
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
National Heart, Lung, and Blood Institute · P01
Project lead · $1.4M · Dana-Farber Cancer Inst
- 1997–2026
Dana-Farber/Harvard Cancer Center
National Cancer Institute · P30
Project lead · $31.3M · Dana-Farber Cancer Inst
Clinical trials
- 2018–2020
Principal investigator · Completed
Dana-Farber Cancer Institute
- 2003–2005
Natural History Study of Patients With Chronic Myelogenous Leukemia
Study chair · Completed
Dana-Farber Cancer Institute